Jones Institute for Reproductive Medicine – FDA 483, Nov 8, 2022
The FDA inspected Jones Institute for Reproductive Medicine in Norfolk, VA, and issued a Form 483 with three observations. The firm failed to adequately screen oocyte donors for communicable disease risk factors, including specific travel and transfusion history, and lacked proper questions for Zika and West Nile Virus. Additionally, HCT/Ps with incomplete donor eligibility were not appropriately labeled, and the firm did not maintain established procedures for testing and screening HCT/P donors for West Nile and Zika Viruses.
- Person
ID · 8eb078ab-1190-4ed6-8e7a-3d6b7a7fbe76
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.